Rise of the Activated Patient During COVID- Biopharma on Notice

ABSTRACT

Today, cancer patients continue to push for their necessary screenings, advocate for surgeries and, for many of them, independently drive their own care while risking their health in an already overwhelmed medical system. [...]patients have lost their jobs and health insurance, compounding the immense stress and anxiety of everyday life. Simultaneously, COVID has negatively impacted clinical trials, which can be more effective at treating cancer patients with advanced therapies compared to the standard of care. Because the pandemic has exposed, and exacerbated, many long-standing issues that patients have dealt with for years that directly impact biopharma.